Key result
Diltiazem preconditioning fails to improve graft patency or enzyme release in a canine MICAB model.
Why the study?
Does preconditioning and proximal ligation improve graft patency in a canine model of minimally invasive coronary bypass grafting?
RCT (n=8)
Randomly conditioned
Does preconditioning and proximal ligation improve graft patency in a canine model of minimally invasive coronary bypass grafting?
Preconditioning and exclusion of competitive flow do not influence left internal mammary artery graft patency in a canine model of minimally invasive coronary bypass grafting.
No support for diltiazem preconditioning in canine model; leaves open translation to human minimally invasive CABG.
The aim of this study was to assess the need for preconditioning and/or exclusion of competitive flow in minimally invasive coronary bypass grafting procedures (MICAB), to prevent early graft occlusion. Eight mongrel dogs (+/- 25 kg) were operated on under intravenous anaesthesia (sodium thiopenthal 15 mg/kg) and maintained with Halothan 1-2% and Pancurorium. A direct anastomosis between the left internal mammary artery and the left anterior descending coronary artery was performed, via anterior distal sternotomy, on the beating heart. Four dogs were preoperatively randomly conditioned by intravenous bolus injection of Diltiazem (0.0025 g/kg) prior to the procedure and after (meanwhile the left internal mammary artery takedown, the proximal coronary artery was snared during 15 min). In the absence of ECG changes or rhythm disturbances, a direct anastomosis of the left internal mammary artery and the left anterior descending coronary artery was performed. In four control dogs, direct MICAB procedure was done without preconditioning. The proximal left anterior descending coronary artery was occluded upstream of the arteriotomy in two dogs from both groups to exclude competitive flow from the native coronary artery. All the procedures were successful, except for one conditioned dog that sustained preoperative transmural anterior myocardial infarction. Cardiac enzymes (CK and CKMB) rose in all groups immediately after the procedure; this was not statistically significant between groups. All survivors were angiographically controlled after 6 to 8 weeks. They showed good patency of all grafts (mean thrombolysis in myocardial infarction-flow equals 2.86). There was perfect matching between the left internal mammary artery and left anterior descending coronary artery in the conditioned and proximal occluded group, which was contrary to the competitive flow in the control groups between the open left anterior descending coronary artery and the left internal mammary artery graft. Permeability of the left internal mammary artery grafts are not influenced by preconditioning nor exclusion of competitive flow in the MICAB technique for the canine model. Graft diameter and flow are merely the result of outflow conditions. In one case, preconditioning was followed by fatal myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Guido Van Nooten (1999) conducted an RCT in Minimally invasive coronary bypass grafting (MICAB) (n=8). Preconditioning (intravenous Diltiazem) and/or proximal coronary occlusion vs. Direct MICAB without preconditioning was evaluated on Graft patency and cardiac enzyme release (p=not statistically significant). Preconditioning with Diltiazem and exclusion of competitive flow did not significantly influence graft patency or cardiac enzyme release in a canine model of minimally invasive coronary bypass grafting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: